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Introduction
Temporal arteritis, also referred to as giant cell arteritis,
is a disease with specific clinical manifestations (in the
advanced stages) and histopathologic findings.1 The
incidence of temporal arteritis varies widely in different
populations, regions, and races. The highest incidences
are found in Scandinavians, and in Americans of
Scandinavian descent. In North America, temporal
arteritis is not uncommon: the incidence in individuals
over 50 years of age is estimated at 0.017%.2 The most
common clinical manifestations of temporal arteritis
are nonspecific, and include headache, low-grade fever,
sweating, anorexia, weight loss, and general malaise.
More specific manifestations, such as claudication of
the jaw, or engorged tender vessels, always develop in
advanced stages of the disorder. In Taiwan, the
prevalence of temporal arteritis, including that of
biopsy-proven cases, has not been reported.
Histologically, 2 distinct types of temporal arteritis
have been proposed: a granulomatous multinucleated
giant cell type and a panarteritis with mixed inflam-
matory cell infiltration.3 The clinical significance of
the different pathologic types of temporal arteritis
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remains to be investigated. Anticardiolipin (aCL) anti-
body, an autoantibody with immunologic reactivity
against phospholipids, plays a role in the thrombosis of
some autoimmune diseases, such as antiphospholipid
syndrome and systemic lupus erythematosus. In
temporal arteritis, thrombosis in the affected vessel is
found only occasionally; however, about 1-third of
patients are positive for aCL antibodies.4 Herein, we
report 2 cases of temporal arteritis with different
pathologic features, and in which 1 of the 2 patients
was positive for aCL antibodies.
Case Reports
Case 1
A 76-year-old man was admitted to Taipei Veterans
General Hospital on 23 June 2003 because of throbbing
headache over the left temporal area that had lasted for
2 weeks, and intermittent claudication over the masseter
area after meals. Three months before admission,
general malaise had developed and the patient had lost
6 kg in body weight. No pain or stiffness over the neck,
shoulder, or pelvic girdle was noted. On admission,
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physical examination disclosed a hard, engorged ves-
sel over the left frontotemporal area of the scalp.
Sonographic studies showed complete obliteration
of the left temporal artery. Biopsy of this vessel and
pathologic studies revealed moderate destruction of
the whole muscle layer, interruption of the internal
elastic layer, and chronic infiltration of inflammatory
cells, including granulomatous multinucleated giant
cells (Figure 1). Further sonographic studies exploring
the extent of vessel involvement in the bilateral common
carotid arteries, internal carotid artery, vertebral and
subclavian arteries, were unremarkable. Although the
patient had no visual problems, a small delayed filling
defect in the retinal vein was detected by fluorescent
angiography.
Laboratory studies disclosed elevation of erythrocyte
sedimentation rate (ESR; 119 mm/hr) and serum
level of C-reactive protein (CRP; 7.21 mg/dL; normal
< 0.50 mg/dL). The immunoglobulin G (IgG) aCL
antibody was positive (28 GPL; normal < 15 GPL).
The following tests were all within normal limits:
complete blood count; urinalysis; routine stool cultures;
hepatic and renal function tests; partial prothrombin
time (PT); activated partial thromboplastin time
(aPTT); and serum levels of IgG, IgA, IgM, anti-
thrombin III, protein C, and protein S. Antinuclear
antibody (ANA), anti-dsDNA, and antineutrophil
cytoplasmic antibodies, were also negative.
After diagnosis, the patient was treated with
prednisolone 10 mg/day. The engorged temporal
artery had become flat and less tender 2 weeks later;
also, headache, mouth claudication and general malaise
improved gradually but markedly. ESR declined from
119 mm/hour to 45 mm/hour 3 weeks after treatment.
Case 2
A 74-year-old man visited our hospital on 4 September
2003 because of general malaise, a nodule-like lesion,
and vague headache over both temporal areas of the
head, and intermittent mouth claudication after meals
for 1 month. No pain or stiffness was noted over the
neck, shoulder, or pelvic girdle. Physical examination
disclosed engorged and firm vessels over both temporal
areas, and sonographic studies showed focal dilation
and thickening of vascular walls in these vessels. Biopsy
of the left temporal artery revealed fibrinoid necrosis,
thickening of the intimal layer, interruption of the
internal elastic lamina, and chronic inflammatory cell
infiltration throughout the vascular layer with
epithelioid histiocytes, plasma cells, lymphocytes, and
eosinophils (Figure 2). The bilateral common carotid
arteries, internal carotid artery, vertebral and subclavian
arteries were unremarkable in sonographic studies.
Laboratory studies disclosed elevation of ESR (115
mm/hr) and serum CRP (10.6 mg/dL). The following
tests were all within normal limits: complete blood
count; urinalysis; routine stool cultures; hepatic and
renal function tests; PT; aPTT; and serum levels of
IgG, IgA, IgM, anti-thrombin III, protein C, and
protein S. ANA, anti-dsDNA, and IgG aCL antibody
were negative.
After diagnosis, because both temporal arteries were
involved, the patient was treated with prednisolone 15
mg/day plus azathioprine 50 mg every other day.
Three weeks later, the hard and engorged temporal
arteries had become less tender, and headache and
mouth claudication had improved; ESR had dropped
from 115 mm/hour to 13 mm/hour, and CRP from
10.6 mg/dL to 1.29 mg/dL. Thus, prednisolone was
tapered to 5 mg/day and azathioprine was discontinued.
Figure 1. Case 1: biopsy from the temporal artery showing
destruction of the muscle layer with granulomatous giant cells
(arrow). (Hematoxylin & eosin, × 200.)
Figure 2. Case 2: biopsy from the temporal artery showing
fibrinoid necrosis of the artery (arrow) and panarteritis with
mixed-cell inflammation, including epithelioid histiocytes, plasma
cells, lymphocytes, and eosinophils, but without multinucleated
giant cells. (Hematoxylin & eosin, × 200).
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Discussion
In this report, both patients had temporal arteritis
after 50 years of age. New-onset headache was the
defining feature in both cases, and ESR values were
high (* 50 mm/hr). Temporal artery biopsies disclosed
the characteristic findings of temporal arteritis, and
these findings satisfied the 1990 American College of
Rheumatology classification criteria for temporal
arteritis.5 Although temporal arteritis and polymyalgia
rheumatica (PMR) can occur simultaneously,1 our
patients did not complain of pain or stiffness in the neck,
shoulder, or pelvic areas. The coexistence of PMR with
temporal arteritis was therefore unlikely in our cases.
Interestingly, aCL antibodies are found in many
autoimmune diseases, including systemic lupus
erythematosus, Sjögren’s syndrome, rheumatoid
arthritis, polymyositis, and dermatomyositis.6 The
incidence of aCL antibodies in temporal arteritis is not
low: about 31–46% of patients with this disorder test
positive for such antibodies.4,7 However, the role of
aCL antibodies in temporal arteritis remains to be
elucidated. In the study by Manna et al,8 aCL antibodies
did not appear to be an important factor in the de-
velopment of vascular complications such as ischemic
stroke, transient ischemic attack, angina pectoris,
myocardial infarction, occlusive ocular vascular dis-
ease, Raynaud’s phenomenon, and jaw claudication.
Conversely, in a prospective, longitudinal study
conducted by Chakravarty et al,9 3 of 5 patients with
temporal arteritis and high levels of aCL antibodies
at presentation progressed to severe vascular
complications, suggesting that elevated aCL levels
may indicate a poor prognosis regarding such
complications. One of our 2 patients was positive for
aCL-IgG, but neither patient had involvement of large
vessels other than the temporal artery. Overall, more
studies are needed to elucidate the relationship between
aCL antibodies and the severity of temporal arteritis
and extent of vessel involvement.
Although multinucleated giant cells are char-
acteristic pathologic findings in temporal arteritis,
such cells are not essential to the diagnosis, because 2
distinct pathologic types of the disorder have been
proposed: a granulomatous multinucleated giant cell
type; and a panarteritis infiltrated with mononuclear
cells, neutrophils, and eosinophils, but without
multinucleated giant cells. The patient in our first
case had granulomatous giant cell temporal arteritis,
whereas our second patient had panarteritis.
Temporal arteritis has rarely been reported in
Taiwan. Since the common clinical manifestations of
the disorder are usually nonspecific, careful physical
examination of the temporal arteries is particularly
important for making an early diagnosis. Further
studies are needed to determine the relationships
between the clinical manifestations of temporal arteritis,
aCL antibodies, and the different pathologic subtypes
of the condition.
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